Business
Jaguar Animal Health to Host Treatment Forum for Veterinarians About Chemotherapy-Induced Diarrhea (CID) in Dogs on Sunday, March 6th, During the Western Veterinary Conference (WVC) in Las Vegas
Canalevia™-CA1, which received conditional approval from the FDA on December 21, 2021, is the first and only treatment for CID in dogs to receive any type of
About this update from Jaguar Health, Inc.
[{"type":"text","content":"Canalevia™-CA1, which received conditional approval from the FDA on December 21, 2021, is the first and only treatment for CID in dogs to receive any type of approval from the FDAU.S. veterinarians, veterinary oncologists, and members of the media can click here to register for the CID Treatment ForumSAN FRANCISCO, CA / ACCESSWIRE / March 1, 2022 / Jaguar Health, Inc. (NASDAQ:JAGX), under its Jaguar Animal Health tradename for the veterinary market, today announced that the company is hosting a treatment forum for veterinarians about chemotherapy-induced diarrhea (CID) in dogs at the Mandalay Bay Resort and Casino in Las Vegas on Sunday, March 6, 2022 from 5:30 PM - 7:30 PM Pacific Time during the Western Veterinary Conference (WVC), which is being held at the same location.Noted veterinary oncologist Dr. Craig A. Clifford, DVM, MS, DACVIM will lead the discussion on the significant burden of disease of chemotherapy-induced diarrhea, share his experience treating dogs with CID, and characterize the clinical profile of Canalevia-CA1, the company's plant-based prescription drug for the treatment of CID in dogs. Dinner will be provided for attendees.Participation Details for CID Treatment Forum:Event Date & Time: Sunday, March 6, 2022, from 5:30 PM - 7:30 PM Pacific TimeEvent Location: Palm H, Level 3 at the Mandalay Bay Resort and Casino in Las Vegas, NVHow to Register: U.S. veterinarians, veterinary oncologists, and members of the media can register on the Canalevia.com website for the CID Treatment Forum by clicking hereCanalevia-CA1 is being commercialized as a prescription drug product under the company's Jaguar Animal Health tradename. As part of the launch of Canalevia-CA1, Jaguar Animal Health is showcasing the product at exhibit booth 872 at WVC, that takes place March 6 - 9, 2022. Additional information about WVC can be found on the conference website by clicking here.About Chemotherapy-induced Diarrhea (CID) in DogsDue to the increasing number of chemotherapeutic agents being adopted by veterinarians and veterinary oncologists, chemotherapy is fast becoming the most widely used cancer treatment in veterinary medicine. Studies have found the incidence of CID to be one of the three most prevalent side effects in dogs undergoing cancer treatment,1 and managing side-effects such as diarrhea can be important to maintain succe...